125 E. 50th St.
New York, NY 10022
The meeting will feature a presentation by key opinion leader Peter Kaufman, MD (University of Vermont) who will discuss the current treatment landscape, as well as the unmet medical need for treating patients with metastatic HER2-negative breast cancer. Dr. Kaufman will be available to answer questions at the conclusion of the event.